Uterine Fibroids Market Research Report Information By Type (Intramural Fibroids, Submucosal Fibroids, Subserosal Fibroids, and Others), By Diagnosis (Computed Tomography (CT), Ultrasounds, Medical Resonance Imaging (MRI) Scanners, and Others), By Treatment (Magnetic Resonance Guided Focused Ultrasound, Myolysis, Uterine Fibroid Embolization, Endometrial Ablation, Hysterectomy, and Myomectomy) And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2032

ID: MRFR/MED/1766-CR | 47 Pages | Author: Rahul Gotadki | February 2021

1 Introduction

1.1.1 Prevalence of the Uterine Fibroids in U.S. 8

2 Scope of Study

2.1 Research Objective 10

2.2 Assumptions & Limitations 10

2.2.1 Assumptions 10

2.2.2 Limitations 10

2.3 Market Structure 11

3 Research Methodology

3.1 Primary Research 13

3.2 Secondary Research 13

4 U.S. Uterine Fibroid Market

4.1 Introduction 15

4.2 U.S. Uterine Fibroid Market, By Type 17

4.3 U.S. Uterine Fibroid Market, By Diagnosis 19

4.4 U.S. Uterine Fibroid Market, By Treatment 21

5 Company Profile

5.1 AstraZeneca 29

5.1.1 Company Overview 29

5.1.2 Product overview 29

5.1.3 Financial Overview 30

5.1.4 Key Development 31

5.1.5 SWOT Analysis 32

5.2 Cook Medical Inc. 33

5.2.1 Overview 33

5.2.2 Product Overview 33

5.2.3 Financials 33

5.2.4 Key Developments 33

5.2.5 SWOT Analysis 34

5.3 Boston Scientific Corporation 35

5.3.1 Company Overview 35

5.3.2 Product/Business Segment Overview 35

5.3.3 Financial Overview 35

5.3.4 Key Development 36

5.3.1 SWOT Analysis 37

5.4 GE Healthcare 38

5.4.1 Company Overview 38

5.4.2 Product/Business Segment Overview 38

5.4.3 Financial Overview 38

5.4.4 Key Development 40

5.4.5 SWOT Analysis 40

5.5 AbbVie Inc. 41

5.5.1 Company Overview 41

5.5.2 Product/Business Segment Overview 41

5.5.3 Financial Overview 41

5.5.4 Key Development 43

5.5.5 SWOT Analysis 43

5.6 Hologic, Inc. 44

5.6.1 Company Overview 44

5.6.2 Product/Business Segment Overview 44

5.6.3 Financial Overview 44

5.6.4 Key Development 46

5.6.5 SWOT Analysis 46

6 List of Tables

TABLE 1 U.S. UTERINE FIBROID MARKET, BY TYPE, 2020-2027 (USD MILLION) 18

TABLE 2 U.S. UTERINE FIBROID MARKET, BY DIAGNOSIS, 2020-2027 (USD MILLION) 20

TABLE 3 U.S. UTERINE FIBROID MARKET, BY TREATMENT, 2020-2027 (USD MILLION) 23

TABLE 4 U.S. UTERINE FIBROID MARKET, BY TREATMENT TYPE, 2020-2027 (USD MILLION) 24

TABLE 5 PIPELINE PRODUCTS FOR UTERINE FIBROIDS 27

TABLE 6 ASTRAZENECA: KEY DEVELOPMENT 31

TABLE 7 BOSTON SCIENTIFIC CORPORATION: KEY DEVELOPMENT 36

TABLE 8 GE HEALTHCARE: KEY DEVELOPMENT 40

TABLE 9 ABBVIE INC.: KEY DEVELOPMENT 43

TABLE 10 HOLOGIC INC.: KEY DEVELOPMENT 46

7 List of Figures

FIGURE 1 COMPARISON BETWEEN DIAGNOSIS & TREATMENT MARKET, 2020-2027 (USD MILLION) 9

FIGURE 2 U.S. UTERINE FIBROID MARKET: MARKET STRUCTURE 11

FIGURE 3 RESEARCH PROCESS 12

FIGURE 4 U.S. UTERINE FIBROID MARKET, BY TYPE, 2023-2032 (USD MILLION) 18

FIGURE 5 U.S. UTERINE FIBROID MARKET, BY DIAGNOSIS, 2023-2032 (USD MILLION) 20

FIGURE 6 TREATMENTS FOR UTERINE FIBROIDS 22

FIGURE 7 U.S. UTERINE FIBROID MARKET, BY TREATMENT, 2020-2027 (USD MILLION) 23

FIGURE 8 U.S. UTERINE FIBROID MARKET, BY TREATMENT TYPE, 2023-2032 (USD MILLION) 24

FIGURE 9 PHARMACOTHERAPY TREATMENT FORECAST, 2020-2027 26

FIGURE 10 ASTRAZENECA: RECENT FINANCIAL 30

FIGURE 11 ASTRAZENECA: GEOGRAPHICAL MIX 30

FIGURE 12 ASTRAZENECA: OPERATING SEGMENTS 31

FIGURE 13 ASTRAZENECA: SWOT ANALYSIS 32

FIGURE 14 BOSTON SCIENTIFIC CORPORATION: RECENT FINANCIAL 35

FIGURE 15 BOSTON SCIENTIFIC CORPORATION: RECENT FINANCIAL 36

FIGURE 16 BOSTON SCIENTIFIC CORPORATION: SWOT ANALYSIS 37

FIGURE 17 GE HEALTHCARE: RECENT FINANCIAL 38

FIGURE 18 GE HEALTHCARE: GEOGRAPHICAL MIX 39

FIGURE 19 GE HEALTHCARE: OPERATING SEGMENTS 39

FIGURE 20 GE HEALTHCARE: SWOT ANALYSIS 40

FIGURE 21 ABBVIE INC.: RECENT FINANCIAL 41

FIGURE 22 ABBVIE INC.: GEOGRAPHICAL MIX 42

FIGURE 23 ABBVIE INC: OPERATING SEGMENTS 42

FIGURE 24 ABBVIE INC.: SWOT ANALYSIS 43

FIGURE 25 HOLOGIC INC.: RECENT FINANCIAL 44

FIGURE 26 HOLOGIC INC: GEOGRAPHICAL MIX 45

FIGURE 27 HOLOGIC INC: OPERATING SEGMENTS 45

FIGURE 28 HOLOGIC INC.: SWOT ANALYSIS 46

Uterine Fibroid Market Segmentation

Uterine Fibroid Type Outlook (USD Billion, 2018-2032)

Subserosal Fibroids

Intramural Fibroids

Submucosal Fibroids

Others

Uterine Fibroid Diagnosis Outlook (USD Billion, 2018-2032)

Medical Resonance Imaging (MRI) Scanners

Computed Tomography (CT)

Ultrasounds

Others

Uterine Fibroid Treatment Outlook (USD Billion, 2018-2032)

Uterine Fibroid Embolization

Magnetic Resonance Guided Focused Ultrasound

Myolysis

Endometrial Ablation

Hysterectomy

Myomectomy

Uterine Fibroid Regional Outlook (USD Billion, 2018-2032)

North America Outlook (USD Billion, 2018-2032)
- North America Uterine Fibroid by Type
  - Subserosal Fibroids
  - Intramural Fibroids
  - Submucosal Fibroids
  - Others
- North America Uterine Fibroid by Diagnosis
  - Medical Resonance Imaging (MRI) Scanners
  - Computed Tomography (CT)
  - Ultrasounds
  - Others
- North America Uterine Fibroid by Treatment
  - Uterine Fibroid Embolization
  - Magnetic Resonance Guided Focused Ultrasound
  - Myolysis
  - Endometrial Ablation
  - Hysterectomy
  - Myomectomy
- US Outlook (USD Billion, 2018-2032)
- US Uterine Fibroid by Type
  - Subserosal Fibroids
  - Intramural Fibroids
  - Submucosal Fibroids
  - Others
- US Uterine Fibroid by Diagnosis
  - Medical Resonance Imaging (MRI) Scanners
  - Computed Tomography (CT)
  - Ultrasounds
  - Others
- US Uterine Fibroid by Treatment
  - Uterine Fibroid Embolization
  - Magnetic Resonance Guided Focused Ultrasound
  - Myolysis
  - Endometrial Ablation
  - Hysterectomy
  - Myomectomy
- CANADA Outlook (USD Billion, 2018-2032)
- CANADA Uterine Fibroid by Type
  - Subserosal Fibroids
  - Intramural Fibroids
  - Submucosal Fibroids
  - Others
- CANADA Uterine Fibroid by Diagnosis
  - Medical Resonance Imaging (MRI) Scanners
  - Computed Tomography (CT)
  - Ultrasounds
  - Others
- CANADA Uterine Fibroid by Treatment
  - Uterine Fibroid Embolization
  - Magnetic Resonance Guided Focused Ultrasound
  - Myolysis
  - Endometrial Ablation
  - Hysterectomy
  - Myomectomy

Europe Outlook (USD Billion, 2018-2032)
- Europe Uterine Fibroid by Type
  - Subserosal Fibroids
  - Intramural Fibroids
  - Submucosal Fibroids
  - Others
- Europe Uterine Fibroid by Diagnosis
  - Medical Resonance Imaging (MRI) Scanners
  - Computed Tomography (CT)
  - Ultrasounds
  - Others
- Europe Uterine Fibroid by Treatment
  - Uterine Fibroid Embolization
  - Magnetic Resonance Guided Focused Ultrasound
  - Myolysis
  - Endometrial Ablation
  - Hysterectomy
  - Myomectomy
- Germany Outlook (USD Billion, 2018-2032)
- Germany Uterine Fibroid by Type
  - Subserosal Fibroids
  - Intramural Fibroids
  - Submucosal Fibroids
  - Others
- Germany Uterine Fibroid by Diagnosis
  - Medical Resonance Imaging (MRI) Scanners
  - Computed Tomography (CT)
  - Ultrasounds
  - Others
- Germany Uterine Fibroid by Treatment
  - Uterine Fibroid Embolization
  - Magnetic Resonance Guided Focused Ultrasound
  - Myolysis
  - Endometrial Ablation
  - Hysterectomy
  - Myomectomy
- France Outlook (USD Billion, 2018-2032)
- France Uterine Fibroid by Type
  - Subserosal Fibroids
  - Intramural Fibroids
  - Submucosal Fibroids
  - Others
- France Uterine Fibroid by Treatment
  - Uterine Fibroid Embolization
  - Magnetic Resonance Guided Focused Ultrasound
  - Myolysis
  - Endometrial Ablation
  - Hysterectomy
  - Myomectomy
- France Uterine Fibroid by Diagnosis
  - Medical Resonance Imaging (MRI) Scanners
  - Computed Tomography (CT)
  - Ultrasounds
  - Others
- UK Outlook (USD Billion, 2018-2032)
- UK Uterine Fibroid by Type
  - Subserosal Fibroids
  - Intramural Fibroids
  - Submucosal Fibroids
  - Others
- UK Uterine Fibroid by Diagnosis
  - Medical Resonance Imaging (MRI) Scanners
  - Computed Tomography (CT)
  - Ultrasounds
  - Others
- UK Uterine Fibroid by Treatment
  - Uterine Fibroid Embolization
  - Magnetic Resonance Guided Focused Ultrasound
  - Myolysis
  - Endometrial Ablation
  - Hysterectomy
  - Myomectomy
- ITALY Outlook (USD Billion, 2018-2032)
- ITALY Uterine Fibroid by Type
  - Subserosal Fibroids
  - Intramural Fibroids
  - Submucosal Fibroids
  - Others
- ITALY Uterine Fibroid by Diagnosis
  - Medical Resonance Imaging (MRI) Scanners
  - Computed Tomography (CT)
  - Ultrasounds
  - Others
- ITALY Uterine Fibroid by Treatment
  - Uterine Fibroid Embolization
  - Magnetic Resonance Guided Focused Ultrasound
  - Myolysis
  - Endometrial Ablation
  - Hysterectomy
  - Myomectomy
- SPAIN Outlook (USD Billion, 2018-2032)
- Spain Uterine Fibroid by Type
  - Subserosal Fibroids
  - Intramural Fibroids
  - Submucosal Fibroids
  - Others
- Spain Uterine Fibroid by Diagnosis
  - Medical Resonance Imaging (MRI) Scanners
  - Computed Tomography (CT)
  - Ultrasounds
  - Others
- Spain Uterine Fibroid by Treatment
  - Uterine Fibroid Embolization
  - Magnetic Resonance Guided Focused Ultrasound
  - Myolysis
  - Endometrial Ablation
  - Hysterectomy
  - Myomectomy
- Rest Of Europe Outlook (USD Billion, 2018-2032)
- Rest Of Europe Uterine Fibroid by Type
  - Subserosal Fibroids
  - Intramural Fibroids
  - Submucosal Fibroids
  - Others
- REST OF EUROPE Uterine Fibroid by Diagnosis
  - Medical Resonance Imaging (MRI) Scanners
  - Computed Tomography (CT)
  - Ultrasounds
  - Others
- Rest Of Europe Uterine Fibroid by Treatment
  - Uterine Fibroid Embolization
  - Magnetic Resonance Guided Focused Ultrasound
  - Myolysis
  - Endometrial Ablation
  - Hysterectomy
  - Myomectomy

Asia-Pacific Outlook (USD Billion, 2018-2032)
- Asia-Pacific Uterine Fibroid by Type
  - Subserosal Fibroids
  - Intramural Fibroids
  - Submucosal Fibroids
  - Others
- Asia-Pacific Uterine Fibroid by Diagnosis
  - Medical Resonance Imaging (MRI) Scanners
  - Computed Tomography (CT)
  - Ultrasounds
  - Others
- Asia-Pacific Uterine Fibroid by Treatment
  - Uterine Fibroid Embolization
  - Magnetic Resonance Guided Focused Ultrasound
  - Myolysis
  - Endometrial Ablation
  - Hysterectomy
  - Myomectomy
- China Outlook (USD Billion, 2018-2032)
- China Uterine Fibroid by Type
  - Subserosal Fibroids
  - Intramural Fibroids
  - Submucosal Fibroids
  - Others
- China Uterine Fibroid by Diagnosis
  - Medical Resonance Imaging (MRI) Scanners
  - Computed Tomography (CT)
  - Ultrasounds
  - Others
- China Uterine Fibroid by Treatment
  - Uterine Fibroid Embolization
  - Magnetic Resonance Guided Focused Ultrasound
  - Myolysis
  - Endometrial Ablation
  - Hysterectomy
  - Myomectomy
- Japan Outlook (USD Billion, 2018-2032)
- Japan Uterine Fibroid by Type
  - Subserosal Fibroids
  - Intramural Fibroids
  - Submucosal Fibroids
  - Others
- Japan Uterine Fibroid by Treatment
  - Uterine Fibroid Embolization
  - Magnetic Resonance Guided Focused Ultrasound
  - Myolysis
  - Endometrial Ablation
  - Hysterectomy
  - Myomectomy
- Japan Uterine Fibroid by Diagnosis
  - Medical Resonance Imaging (MRI) Scanners
  - Computed Tomography (CT)
  - Ultrasounds
  - Others
- India Outlook (USD Billion, 2018-2032)
- India Uterine Fibroid by Type
  - Subserosal Fibroids
  - Intramural Fibroids
  - Submucosal Fibroids
  - Others
- India Uterine Fibroid by Diagnosis
  - Medical Resonance Imaging (MRI) Scanners
  - Computed Tomography (CT)
  - Ultrasounds
  - Others
- India Uterine Fibroid by Treatment
  - Uterine Fibroid Embolization
  - Magnetic Resonance Guided Focused Ultrasound
  - Myolysis
  - Endometrial Ablation
  - Hysterectomy
  - Myomectomy
- Australia Outlook (USD Billion, 2018-2032)
- Australia Uterine Fibroid by Type
  - Subserosal Fibroids
  - Intramural Fibroids
  - Submucosal Fibroids
  - Others
- Australia Uterine Fibroid by Treatment
  - Uterine Fibroid Embolization
  - Magnetic Resonance Guided Focused Ultrasound
  - Myolysis
  - Endometrial Ablation
  - Hysterectomy
  - Myomectomy
- Australia Uterine Fibroid by Diagnosis
  - Medical Resonance Imaging (MRI) Scanners
  - Computed Tomography (CT)
  - Ultrasounds
  - Others
- Rest of Asia-Pacific Outlook (USD Billion, 2018-2032)
- Rest of Asia-Pacific Uterine Fibroid by Type
  - Subserosal Fibroids
  - Intramural Fibroids
  - Submucosal Fibroids
  - Others
- Rest of Asia-Pacific Uterine Fibroid by Treatment
  - Uterine Fibroid Embolization
  - Magnetic Resonance Guided Focused Ultrasound
  - Myolysis
  - Endometrial Ablation
  - Hysterectomy
  - Myomectomy
- Rest of Asia-Pacific Uterine Fibroid by Diagnosis
  - Medical Resonance Imaging (MRI) Scanners
  - Computed Tomography (CT)
  - Ultrasounds
  - Others

Rest of the World Outlook (USD Billion, 2018-2032)
- Rest of the World Uterine Fibroid by Type
  - Subserosal Fibroids
  - Intramural Fibroids
  - Submucosal Fibroids
  - Others
- Rest of the World Uterine Fibroid by Treatment
  - Uterine Fibroid Embolization
  - Magnetic Resonance Guided Focused Ultrasound
  - Myolysis
  - Endometrial Ablation
  - Hysterectomy
  - Myomectomy
- Rest of the World Uterine Fibroid by Diagnosis
  - Medical Resonance Imaging (MRI) Scanners
  - Computed Tomography (CT)
  - Ultrasounds
  - Others
- Middle East Outlook (USD Billion, 2018-2032)
- Middle East Uterine Fibroid by Type
  - Subserosal Fibroids
  - Intramural Fibroids
  - Submucosal Fibroids
  - Others
- Middle East Uterine Fibroid by Diagnosis
  - Medical Resonance Imaging (MRI) Scanners
  - Computed Tomography (CT)
  - Ultrasounds
  - Others
- Middle East Uterine Fibroid by Treatment
  - Uterine Fibroid Embolization
  - Magnetic Resonance Guided Focused Ultrasound
  - Myolysis
  - Endometrial Ablation
  - Hysterectomy
  - Myomectomy
- Africa Outlook (USD Billion, 2018-2032)
- Africa Uterine Fibroid by Type
  - Subserosal Fibroids
  - Intramural Fibroids
  - Submucosal Fibroids
  - Others
- Africa Uterine Fibroid by Diagnosis
  - Medical Resonance Imaging (MRI) Scanners
  - Computed Tomography (CT)
  - Ultrasounds
  - Others
- Africa Uterine Fibroid by Treatment
  - Uterine Fibroid Embolization
  - Magnetic Resonance Guided Focused Ultrasound
  - Myolysis
  - Endometrial Ablation
  - Hysterectomy
  - Myomectomy
- Latin America Outlook (USD Billion, 2018-2032)
- Latin America Uterine Fibroid by Type
  - Subserosal Fibroids
  - Intramural Fibroids
  - Submucosal Fibroids
  - Others
- Latin America Uterine Fibroid by Diagnosis
  - Medical Resonance Imaging (MRI) Scanners
  - Computed Tomography (CT)
  - Ultrasounds
  - Others
- Latin America Uterine Fibroid by Treatment
  - Uterine Fibroid Embolization
  - Magnetic Resonance Guided Focused Ultrasound
  - Myolysis
  - Endometrial Ablation
  - Hysterectomy
  - Myomectomy

Leading companies partner with us for data-driven Insights.

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Request Free Sample

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.

Ask for Customization

Related Reports

Uterine Fibroid Treatment Device Market Research Report 2032

Leuprolide Acetate Market Research Report - Forecast to 2030

Press Release

United States Uterine Fibroid Market Multiply Relentlessly; Asserts MRFR Unleashing Industry Fore...